NDC 66689-028-01 - Levetiracetam

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
66689-028
Requested NDC
66689-028-01
Package NDCs from labels
66689-028-01, 66689-028-50
Manufacturer
VistaPharm, LLC
Effective date
2022-11-30
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
Levetiracetam - VistaPharm, LLCVistaPharm, LLC2022-11-30HUMAN PRESCRIPTION DRUG LABEL
National Council for Prescription Drug Programs indexing - billing unitNational Council for Prescription Drug Programs2012-07-24Indexing - Billing Unit

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
66689-028-01ML - Milliliter66689-02854873b8a-90c5-453e-bc14-4ce23bc212d212012-07-24
66689-028-50ML - Milliliter66689-028a8c7728e-1bbd-4637-9c28-3865ce4ee85e12012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
LevetiracetamACTIVE INGREDIENT44YRR34555LEVETIRACETAM SOLUTION [VISTAPHARM, INC]2
LevetiracetamACTIVE MOIETY44YRR34555LEVETIRACETAM SOLUTION [VISTAPHARM, INC]2
acesulfame potassiumINACTIVE INGREDIENT23OV73Q5G9LEVETIRACETAM SOLUTION [VISTAPHARM, INC]2
citric acid monohydrateINACTIVE INGREDIENT2968PHW8QPLEVETIRACETAM SOLUTION [VISTAPHARM, INC]2
glycerinINACTIVE INGREDIENTPDC6A3C0OXLEVETIRACETAM SOLUTION [VISTAPHARM, INC]2
glycyrrhizin, ammoniatedINACTIVE INGREDIENT3VRD35U26CLEVETIRACETAM SOLUTION [VISTAPHARM, INC]2
maltitolINACTIVE INGREDIENTD65DG142WKLEVETIRACETAM SOLUTION [VISTAPHARM, INC]2
methylparabenINACTIVE INGREDIENTA2I8C7HI9TLEVETIRACETAM SOLUTION [VISTAPHARM, INC]2
propylparabenINACTIVE INGREDIENTZ8IX2SC1OHLEVETIRACETAM SOLUTION [VISTAPHARM, INC]2
trisodium citrate dihydrateINACTIVE INGREDIENTB22547B95KLEVETIRACETAM SOLUTION [VISTAPHARM, INC]2
waterINACTIVE INGREDIENT059QF0KO0RLEVETIRACETAM SOLUTION [VISTAPHARM, INC]2

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 26 of 36 · 709 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
LevetiracetamLEVETIRACETAMXLCare Pharmaceuticals Inc.567f09e6-ccd5-4688-a22b-0bc66a5fe31e2024-09-06Warnings, Adverse reactionsExact identifier
unii: 44YRR34555
levetiracetamLEVETIRACETAMNovadoz Pharmaceuticals LLC1ec4c05d-7fba-4c02-a3bf-4343a8a421d52024-08-28Warnings, Adverse reactionsExact identifier
rxcui: 403884
unii: 44YRR34555
EmpathyAETHUSA CYNAPIUM, AMBRA GRISEA, ARGEMONE MEXICANA, CANDIDA ALBICANS, CARLSBAD AQUA, CEREBRUM SUIS, COCCULUS INDICUS, COFFEA TOSTA, CROCUS SATIVUS, CYCLAMEN EUROPAEUM, MAGNESIA CARBONICA, NATRUM CARBONICUM, NUPHAR LUTEUM, NUX MOSCHATA, PHOSPHORUS, PLACENTA TOTALIS SUIS, ROSA DAMASCENA, SUCCINUM, VIOLA ODORATADeseret Biologicals, Inc.a89067c1-ef12-49da-8fa6-e65ff664f4972024-08-13WarningsExact identifier
unii: 059QF0KO0R
LevetiracetamLEVETIRACETAMBryant Ranch Prepackb738377c-035e-4b2e-9909-0a8fe07aa0fb2024-08-12Warnings, Adverse reactionsExact identifier
unii: 44YRR34555
Up and Up Hemorrhoid MAX STRENGTH14.4% GLYCERIN, 0.25% PHENYLEPHRINE HCL, 1% PRAMOXINE HCL, 15% PETROLATUMTarget Corporation867677b5-fd1d-449e-966e-1de0b5c98afb2024-08-08WarningsExact identifier
unii: PDC6A3C0OX
LevetiracetamLEVETIRACETAM ORALCamber Pharmaceuticals, Inc.0bc8468f-832c-4e71-95a2-db464d4d54bc2024-08-03Warnings, Adverse reactionsExact identifier
rxcui: 403884
unii: 44YRR34555
LevetiracetamLEVETIRACETAMScieGen Pharmaceuticals, Inc.1d71212b-ac97-4a61-8192-8e83035400192024-08-01Warnings, Adverse reactionsExact identifier
unii: 44YRR34555
LevetiracetamLEVETIRACETAMMajor Pharmaceuticals423d2185-0931-4414-8864-7594000809ee2024-07-31Warnings, Adverse reactionsExact identifier
rxcui: 403884
unii: 44YRR34555
Levetiracetam Extended-ReleaseLEVETIRACETAMScieGen Pharmaceuticals, Inc3e32f341-9926-47a3-a942-d8b9bfa7a55b2024-07-12Warnings, Adverse reactionsExact identifier
unii: 44YRR34555
Thompson Safety EyewashWATERThompson Safety1d0e96cf-245b-cfb7-e063-6294a90a4ced2024-07-12WarningsExact identifier
unii: 059QF0KO0R
Zenibell Snail IntensiveCreamGLYCERINMISOCOS97c19dca-237c-c968-e053-2a95a90aeae72024-07-05WarningsExact identifier
unii: PDC6A3C0OX
Zenibell Snail Intensive TonerGLYCERINMISOCOS97c1b556-824d-bef7-e053-2a95a90ae1f22024-07-05WarningsExact identifier
unii: PDC6A3C0OX
aewajin Derma HydrocellGLYCERINMISOCOS980fcaea-27ba-da49-e053-2995a90ad5062024-07-05WarningsExact identifier
unii: PDC6A3C0OX
aewajin Derma Hydrocell 24k Gold SerumGLYCERINMISOCOSa17b2c6e-9db8-bae4-e053-2a95a90adcf62024-07-05WarningsExact identifier
unii: PDC6A3C0OX
Bunnies Bum Soothing HemorrhoidalGLYCERIN, LIDOCAINE, PETROLATUM, PHENYLEPHRINE HCLFloCal Distributors LLC1c81582c-7ece-182f-e063-6294a90a8fbc2024-07-05WarningsExact identifier
unii: PDC6A3C0OX
Zenibell Snail IntensiveGLYCERINMISOCOS97747267-26f1-d06f-e053-2a95a90ab0872024-07-04WarningsExact identifier
unii: PDC6A3C0OX
LevetiracetamLEVETIRACETAMAmerican Health Packaging031a32e1-675a-4efe-a66b-40beb4fe51012024-06-21Warnings, Adverse reactionsExact identifier
unii: 44YRR34555
ABREVA Rapid Pain ReliefGLYCERIN, LIDOCAINEHaleon US Holdings LLC65bd242f-4c6a-436c-8ec0-7b2e0d73ed9d2024-06-20WarningsExact identifier
unii: PDC6A3C0OX
Eyesaline Emergency EyewashPURIFIED WATERHoneywell Safety Products USA, Inc.ad42a7e3-84ea-390d-e053-2a95a90a3a322024-06-14WarningsExact identifier
unii: 059QF0KO0R
MegaBabe Butt Stuff HemorrhoidalCOCOA BUTTER, GLYCERIN, LIDOCAINE, PETROLATUM, PHENYLEPHRINE HYDROCHLORIDEMEGABABE, LLC01c156ff-69f9-4d5e-a9ea-abbc52d4afff2024-06-12WarningsExact identifier
unii: PDC6A3C0OX

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.